Pramipexole Dihydrochloride

CAS 104632-26-0 23 current records 1 historicalSmall Molecule

Who holds supplier records for Pramipexole Dihydrochloride? 23 organisations hold a current record for Pramipexole Dihydrochloride: an active US FDA Type II Drug Master File or a CEP. A further 1 organisation has only historical (inactive) DMF filings. 13 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (14), Malta (1), Germany (1), Spain (1) and 5 other countries (5); not recorded for 1.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Pramipexole Dihydrochloride: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/pramipexole-dihydrochloride

Reading the evidence

  • 23 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    14 of the 22 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 18 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (23)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Pramipexole Dihydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Pramipexole Dihydrochloride sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (13)

Certificates of Suitability on the EDQM register for Pramipexole Dihydrochloride, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 18 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
MATRIX PHARMACORP PRIVATE LIMITED SangareddyIN
CEP 2011-038 - Rev 07
Pramipexole dihydrochloride monohydrate
Jul 2026—
ALEMBIC PHARMACEUTICALS LIMITED VadodaraIN
CEP 2011-190 - Rev 01
Pramipexole dihydrochloride monohydrate
Apr 2026—
HETERO DRUGS LIMITED HyderabadIN
CEP 2010-328 - Rev 04
Pramipexole dihydrochloride monohydrate
Apr 2025—
MSN LABORATORIES PRIVATE LIMITED Rudraram VillageIN
CEP 2011-050 - Rev 02
Pramipexole dihydrochloride monohydrate
Mar 2025—
BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG Ingelheim Am RheinDE
CEP 2019-186 - Rev 01
Pramipexole dihydrochloride monohydrate
Mar 2025Inspected Nov 2025
Germany
UNICHEM LABORATORIES LIMITED MumbaiIN
CEP 2012-193 - Rev 01
Pramipexole dihydrochloride monohydrate
Nov 2024—
CIPLA LIMITED MumbaiIN
CEP 2011-047 - Rev 03
Pramipexole dihydrochloride monohydrate
Jul 2024—
APITORIA PHARMA PRIVATE LIMITED HyderabadIN
CEP 2009-292 - Rev 03
Pramipexole dihydrochloride monohydrate
Nov 2023—
CURIA SPAIN S.A.U. BoecilloES
R1-CEP 2010-354 - Rev 01
Pramipexole dihydrochloride monohydrate
Aug 2021—
CHR. OLESEN SYNTHESIS A/S HvidovreDK
R1-CEP 2010-174 - Rev 01
Pramipexole dihydrochloride monohydrate
Apr 2020—
Amino Chemicals LTD. MarsaMT
R1-CEP 2011-127 - Rev 02
Pramipexole dihydrochloride monohydrate
Sept 2018—
SYNTHON BV NijmegenNL
R1-CEP 2010-375 - Rev 00
Pramipexole dihydrochloride monohydrate
May 2018—
APOTEX PHARMACHEM INDIA PVT. LTD BangaloreIN
R1-CEP 2011-112 - Rev 00
Pramipexole dihydrochloride monohydrate
Feb 2018—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (1)

Organisations whose Type II DMFs for Pramipexole Dihydrochloride are no longer active. These show a past filing, not current supply.

Show all 1 historical record

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Pramipexole Dihydrochloride is a dopamine agonist primarily used in the treatment of Parkinson's disease and restless legs syndrome. It works by stimulating dopamine receptors in the brain, thereby alleviating symptoms associated with dopamine deficiency.

Chemical identity

IUPAC name
(6S)-6-N-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine;hydrate;dihydrochloride
Canonical SMILES
CCCN[C@H]1CCC2=C(C1)SC(=N2)N.O.Cl.Cl
InChIKey
APVQOOKHDZVJEX-QTPLPEIMSA-N
Synonyms
Mirapex API, daquiran, mirapex, mirapexin, oprymea, pnu-98528e, pramipexole accord, pramipexole dihydrochloride monohydrate, pramipexole hydrochloride, pramipexole hydrochloride hydrate, pramipexole hydrochloride monohydrate, pramipexole teva

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Nonergot Dopamine Agonist
Mechanism of action
Dopamine Agonists

Therapeutic areas

NeurologyMovement Disorders

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Pramipexole Dihydrochloride?

23 organisations hold an active US FDA Type II Drug Master File or a CEP for Pramipexole Dihydrochloride: Alembic Pharmaceuticals Limited (India), Amino Chemicals Ltd (Malta), APITORIA PHARMA PRIVATE LTD (India), BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG (Germany), CURIA SPAIN SAU (Spain), Hetero Drugs Limited (India), MATRIX PHARMACORP PRIVATE LTD (India) and MSN Laboratories Private Limited (India), and 15 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Pramipexole Dihydrochloride Drug Master Files are active?

Alembic Pharmaceuticals Limited (DMF 18836), Amino Chemicals Ltd (DMF 18297), APITORIA PHARMA PRIVATE LTD (DMF 22789), BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG (DMF 21413), CURIA SPAIN SAU (DMF 21791), Hetero Drugs Limited (DMF 19853), MATRIX PHARMACORP PRIVATE LTD (DMF 21712) and MSN Laboratories Private Limited (DMF 23900) and 11 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Pramipexole Dihydrochloride records mean?

1 organisation has only inactive Type II DMFs for Pramipexole Dihydrochloride. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Pramipexole Dihydrochloride have a European Certificate of Suitability?

Yes. 13 organisations hold a valid CEP for Pramipexole Dihydrochloride on the EDQM register, including MATRIX PHARMACORP PRIVATE LIMITED Sangareddy (IN), ALEMBIC PHARMACEUTICALS LIMITED Vadodara (IN), HETERO DRUGS LIMITED Hyderabad (IN), MSN LABORATORIES PRIVATE LIMITED Rudraram Village (IN), BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG Ingelheim Am Rhein (DE) and UNICHEM LABORATORIES LIMITED Mumbai (IN) and 7 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Pramipexole Dihydrochloride supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Pramipexole Dihydrochloride?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.